You are being redirected because this document is part of your ASTM Compass® subscription.
    This document is part of your ASTM Compass® subscription.

    If you are an ASTM Compass Subscriber and this document is part of your subscription, you can access it for free at ASTM Compass
    STP1051

    Facing Frankenstein: The Importance of Public Participation

    Published: 01 January 1990


      Format Pages Price  
    PDF (80K) 5 $25   ADD TO CART
    Complete Source PDF (2.3M) 155 $55   ADD TO CART

    Cite this document

    X Add email address send
    X
      .RIS For RefWorks, EndNote, ProCite, Reference Manager, Zoteo, and many others.   .DOCX For Microsoft Word


    Abstract

    As the story of Frankenstein showed almost two centuries ago, the public will be frightened and uncooperative if they do not understand the nature of scientific experiments that take place in their communities. Thus, it is extremely important to the future success of the biotechnology industry that both government and industry be responsive to public concerns about biotechnological testing. First, we must do everything in our power to ensure that the release of new organisms into the environment poses no threat to human health or natural ecosystems. And, second, we must take pains to alleviate public concerns about the risks associated with biotechnology, whether those concerns are well-founded or not. The achievement of both these ends requires the involvement of a technically capable, publicly credible regulatory agency.

    Keywords:

    bioprocessing, biotechnology, public education, government regulation, Environmental Protection Agency, safety, public opinion, Frankenstein


    Author Information:

    Barnes, AJ
    Deputy administrator, U.S. Environmental Protection Agency, Washington, DC


    Committee/Subcommittee: E48.01

    DOI: 10.1520/STP26076S